Benzene, (2-butoxyethyl)-
Common Name: |
Benzene, (2-butoxyethyl)- |
IUPAC Name: |
2-butoxyethylbenzene |
Molecular Formula: |
C12H18O |
SMILES: |
CCCCOCCC1=CC=CC=C1 |
Inchi: |
1S/C12H18O/c1-2-3-10-13-11-9-12-7-5-4-6-8-12/h4-8H,2-3,9-11H2,1H3 |
Inchi Key: |
KLJOZKBZXLRMLU-UHFFFAOYSA-N |
Cas No: |
5331-14-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
178.27 |
Mass (g/mol) |
178.136 |
Molar Refractivity |
56.53 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
9.23 |
Hetero Atoms |
1 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
234.00 to 235.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.078 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
3.046 |
iLOGP |
2.97 |
XLOGP3 |
3.29 |
WLOGP |
3.05 |
MLOGP |
3.06 |
ESOL Log S |
-2.96 |
ESOL Solubility (mg/ml) |
0.194 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.16 |
Ali Solubility (mg/ml) |
0.12 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-4.55 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.05 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.872 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.573 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |